PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM REPORTS IND APPLICATION UPDATE, page-59

  1. 76 Posts.
    lightbulb Created with Sketch. 18
    I think you forget that many investors - me included - are not as sophisticated as you lot generally are in terms of pharmaceuticals' regulatory process, impact of delay etc. We can't read between the lines. On a therefore more superficial level, it is a good announcement. SP up methinks.





 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.